Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03462797 · ClinicalTrials.gov registry record
Opioid Physiology Project
A clinical trial, sponsored by University of Tennessee.
- Completed
- Registry status
- 87
- Enrollment target
NCT03462797: Completed study, sponsored by University of Tennessee.
NCT03462797 is a clinical trial that has completed, run by University of Tennessee. The registered enrollment target is 87 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03462797 has completed, sponsored by University of Tennessee.
- COMPLETED
- Registry status
- 87 participants
- Enrollment target
Study Summary
The current project seeks to explore the use of emergent biosensor technology to detect opioid use. The investigators goal is to recruit 60 opioid naïve patients presenting at the College of Dentistry at UTHSC. Candidate participants must be scheduled for an upcoming dental procedure that will involve subsequent pain management using oral opioid medication. Participants will be consented prior to any study procedures. All participant information from this study will be kept strictly confidential (e.g., no individual data will be shared with the College of Dentistry).
Primary Outcome
We will be measuring physiological changes from pre- to post-opioid administration through the Empatica E4 electronic wristband. This device measures 5 physiological parameters: 1. Physical activity through an accelerometer measuring movement on x,y, and z axes. 2. Heart rate measured in beats per minute (BMP) 3. Skin conductance measured in µs (microseconds) 4. Temperature measured in Celsius (°C) 5. Blood volume pulse measured in nm (nanometers) and DNA methylation after self administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2017-08-14 |
| Est. Completion | 2018-10-05 |
What the finished NCT03462797 record still lists
NCT03462797 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 87 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03462797 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03462797 about?
NCT03462797 is a clinical study titled "Opioid Physiology Project". The current project seeks to explore the use of emergent biosensor technology to detect opioid use. The investigators goal is to recruit 60 opioid naïve patients presenting at the College of Dentistry at UTHSC. Candidate participants must be scheduled for an upcoming dental procedure that will invol...
What is the current status of trial NCT03462797?
This trial is currently completed. The enrollment target is 87 participants. The study started on 2017-08-14. Estimated completion is 2018-10-05.
Who is sponsoring clinical trial NCT03462797?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI